Damage Evaluation in the pharmaceutical industry

The period immediately preceding the termination of distribution agreements between manufacturers and distributors, usually long-term lasting, represents a critical moment in the relationships between the parts, especially considering the possible renewal. During these phases the risk of litigation increases and often leads to damage refund claims due to contractual infringements.

Competence Area:

Litigation and damage estimation

Industry:

Pharma & Health Care

Launch and positioning of a new drug

Evaluation of the potential market entry volume, of the positioning and of the communication strategy for the launch of a new drug formulation for the treatment of asthma and chronic bronchitis.

Competence Area:

Business Consulting

Industry:

Pharma & Health Care

Economic appraisal for a producer of an oncologic drug

Development of an economic appraisal aimed at estimating the alleged damage suffered by a producer of an oncologic drug, because of the breach of the distributorship agreement by the Italian distributor of such drug

Competence Area:

Litigation and damage estimation

Industry:

Pharma & Health Care

Business valuation concerning a logistic operator in the pharmaceutical sector

The project of business valuation has been carried out using a main method and a control technique. In order to correctly assess company's prospective economic flows, VVA has built different market scenarios, with the involvement of influential and competent opinion leaders, experts on the sector

Competence Area:

Business & Intagibles evaluation

Industry:

Pharma & Health Care